2-(p toluene sulphonyloxymethyl) 6-methyl 2,3-dihydro [4H] 1,4-benzodioxin | 89483-79-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(p toluene sulphonyloxymethyl) 6-methyl 2,3-dihydro [4H] 1,4-benzodioxin
• 英文别名: 2-tosyloxymethyl 6-methyl 1,4-benzodioxan；(6-Methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl 4-methylbenzenesulfonate
• CAS: 89483-79-4
• 化学式: C₁₇H₁₈O₅S
• 分子量: 334.393
• InChiKey: YPLPUMJCHCMETL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  70.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(p toluene sulphonyloxymethyl) 6-methyl 2,3-dihydro [4H] 1,4-benzodioxin 、 5-氯-1,3-二氢-1-(4-哌啶基)-2H-苯并咪唑-2-酮 在 三乙胺 、 potassium iodide 作用下， 以 二甲基亚砜 为溶剂， 反应 20.0h， 以43%的产率得到1-[(6-Methyl-benzo-1,4-dioxan-2-yl)-methyl]-4-(5-chlorobenzimidazol-2-on-1-yl)-piperidine
  参考文献：
  名称：

  Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzimidazolone derivatives

  摘要：

  A series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzimid azolones with various substituents in both aromatic rings have been synthesized and tested for neuroleptic activity (antiapomorphine effects and [3H]spiroperidol binding) as well as extrapyramidal effects (cataleptogenic effect). A strong dependence of activity on the 5-substituent in the benzimidazolone moiety could be demonstrated. Some compounds show a large split between the desired antiapomorphine and the undesired extrapyramidal effect. From these, 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]-5-chlor obenzimidazol-2-one hydrochloride (HR 723), 12, has been selected for further preclinical and toxicological profiling.

  DOI：

  10.1021/jm00388a012

文献信息

• Antihypertensive cyanoguanidines
  申请人：Bouchara S.A.

  公开号：US04579845A1

  公开（公告）日：1986-04-01

  This invention relates to novel tri-substituted guanidines linked to a piperidine ring. More specifically, it relates to cyanoguanidines of formula I ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 are substituents n is an integer of zero to 1 n' is an integer of zero to 1 A and B are --CH.sub.2 --, CHOH, --CO-- or a single bond as well as the acid addition salts thereof with a mineral or organic acid. The compounds have interesting pharmacological properties which make them useful as active ingredient of medicines, e.g. antihypertensives.

  这项发明涉及与哌啶环相连的新型三取代胍啉。更具体地说，它涉及式I的氰胍啉##STR1##其中R.sub.1、R.sub.2、R.sub.3、R.sub.4是取代基，n是0到1的整数，n'是0到1的整数，A和B是--CH.sub.2 --、CHOH、--CO--或单键，以及它们与矿物酸或有机酸的酸盐。这些化合物具有有趣的药理特性，使它们可用作药物的活性成分，例如抗高血压药。
• HENNING R.; LATTRELL R.; GARHARDS H. J.; LEVEN M., J. MED. CHEM., 30,(1987) N 5, 814-819
  作者：HENNING R.、 LATTRELL R.、 GARHARDS H. J.、 LEVEN M.

  DOI：——

  日期：——
• US4432984A
  申请人：——

  公开号：US4432984A

  公开（公告）日：1984-02-21
• US4579845A
  申请人：——

  公开号：US4579845A

  公开（公告）日：1986-04-01
• [EN] ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS<br/>[FR] DÉRIVÉS D'HÉTÉRO-ARYLE ANTIDÉPRESSEURS DE BENZODIOXANES CONDENSÉS AVEC UN HÉTÉROCYCLE
  申请人：WYETH CORP

  公开号：WO2008150848A1

  公开（公告）日：2008-12-11

  [EN] The invention provides compounds of the Formula: (I) that are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre- menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa, bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses. The compounds are able to block the recptake of serotonin and are modulators at brain 5HT1A serotonin receptors.
  [FR] La présente invention concerne des composés de formule : qui sont utiles pour le traitement de la dépression (comprenant, de manière non restrictive, les troubles dépressifs majeurs, la dépression juvénile et la dysthymie), l'anxiété, les troubles paniques, les troubles liés au stress post-traumatique, les troubles dysphoriques prémenstruels (connus également sous le nom de syndrome prémenstruel), les troubles avec déficit d'attention (avec et sans hyperactivité), les troubles obsessionnels compulsifs, les troubles anxieux sociaux, les troubles anxieux généralisés, l'obésité, les troubles alimentaires tels que l'anorexie mentale, la boulimie nerveuse, les bouffées vasomotrices, la dépendance à la cocaïne et à l'alcool, les dysfonctionnements sexuels et les maladies apparentées. Les composés sont capables de bloquer la recapture de la sérotonine et sont des modulateurs au niveau des récepteurs cérébraux de la sérotonine 5HT1A.